Ignite Creation Date:
2024-05-05 @ 9:56 PM
Last Modification Date:
2024-10-26 @ 10:11 AM
Study NCT ID:
NCT00996346
Status:
TERMINATED
Last Update Posted:
2015-09-01
First Post:
2009-10-14
Brief Title:
Phase III Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas
Sponsor:
New Mexico Cancer Care Alliance
Organization:
New Mexico Cancer Care Alliance
Organization Data
Organization:
New Mexico Cancer Care Alliance
Class:
OTHER
Study ID:
INST 0909
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
New Mexico Cancer Care Alliance
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | INDUSTRY |